Immunophenotypic and functional characterization of CD33+CD34+ cells in human cord blood of preterm neonates

Experimental Hematology

Volumn 28, Issue 10, 2000, Pages 1174-1180

  Jin, Cheng Hao ^a   Takada, Hidetoshi ^a   Nomura, Akihiko ^a   Takahata, Yasushi ^a   Nakayama, Hideki ^a   Kajiwara, Makoto ^b   Nakano, Hitoo ^a   Hara, Toshiro ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b OITA PREFECTURAL HOSPITAL   (Japan)

Author keywords

CD33+CD34+ cell; Cord blood; Hematopoietic stem cell and primitive progenitor cell; Preterm neonate

Indexed keywords

CD33 ANTIGEN; CD34 ANTIGEN; CD38 ANTIGEN; MESSENGER RNA; STEM CELL FACTOR RECEPTOR; TRANSCRIPTION FACTOR GATA 2;

ARTICLE; BONE MARROW CELL; FLOW CYTOMETRY; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; NEWBORN; PREMATURITY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UMBILICAL CORD BLOOD;

ANTIGENS, CD; ANTIGENS, CD34; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BLOTTING, SOUTHERN; BONE MARROW CELLS; CELL SEPARATION; CELLS, CULTURED; DNA-BINDING PROTEINS; FETAL BLOOD; FLOW CYTOMETRY; GENE EXPRESSION; HEMATOPOIETIC STEM CELLS; HUMAN; IMMUNOPHENOTYPING; INFANT, NEWBORN; INFANT, PREMATURE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T; TRANSCRIPTION FACTORS;

EID: 0033797530     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(00)00519-1     Document Type: Article

References (28)

1. Metcalf D (1971) Hematopoietic cells. New York: North Holland Press.
2. Krause D.S., Fackler M.J., Civin C.I., May W.S. CD34. structure, biology, and clinical utility Blood. 87:1996;1.
3. - cells in cord blood and bone marrow. Blood. 86:1995;3745.
4. + bone marrow cells. Blood. 84:1994;1473.
5. + progenitor cells isolated from human bone marrow are functionally distinct. Blood. 91:1998;1947.
6. Rappold I., Ziegler B.L., Kohler I.et al. Functional and phenotypic characterization of cord blood and bone marrow subsets expressing FLT3 (CD135) receptor tyrosine kinase. Blood. 90:1997;111.
7. + cells expressing different levels of HLA-DR, CD33, CD38 and c-kit antigens. Stem Cell. 15:1997;73.
8. + human marrow cells to establish in vitro hematopoiesis in long-term marrow cultures. Exp Hematol. 20:1992;442.
9. Craig W., Kay R., Culter R.L., Lansdorp P.M. Expression of Thy-1 on human hematopoietic progenitor cells. J Exp Med. 177:1993;1331.
10. - hematopoietic stem cells. Blood. 83:1994;1515.
11. +). Exp Hematol. 19:1991;680.
12. + human marrow cells that express low levels of Kit protein are enriched for long-term marrow-engrafting cells. Blood. 87:1996;4136.
13. high cells. Blood. 82:1993;3283.
14. Muench M.O., Roncarolo M.G., Namikawa R. Phenotypic and functional evidence for the expression of CD4 by hematopoietic stem cells isolated from human fetal liver. Blood. 89:1997;1364.
15. + hemopoietic cells from human bone marrow. J Exp Med. 172:1990;363.
16. + myeloid progenitors using CD45-RA analysis. Blood. 81:1993;2301.
17. Louache F., Debili N., Marandin A., Coulombel L., Vainchenker W. Expression of CD4 by human hematopoietic progenitors. Blood. 84:1994;3344.
18. + human fetal liver progenitors with a high proliferative potential. Blood. 83:1994;3170.
19. + hematopoietic stem/progenitor cells in fetal cord blood. Am J Obstet Gynecol. 178:1998;931.
20. Thilaganathan B., Nicolaides K.H., Morgan G. Subpopulations of CD34-positive haemopoietic progenitors in fetal blood. Br J Haematol. 87:1994;634.
21. Clapp W., Baley J., Gerson S. Gestational age-dependent changes in circulating hematopoietic stem cells in newborn infants. J Lab Clin Med. 113:1989;422.
22. Miller DR (1995) Origin and development of blood cells and coagulation factors: maternal-fetal interactions In: Blood diseases of infancy and childhood, 7th edition. York, PA: Mosby-Year Book Inc Press, p. 3.
23. Freeman S.D., Kelm S., Barber E.K., Crocker P.R. Characterization of CD33 as a new member of the sialoadhesin family of cellular interaction molecules. Blood. 85:1995;2005.
24. Orlic D., Anderson S., Biesecker L.G., Sorrentino B.P., Bodine D.M. Pluripotent hematopoietic stem cells contain high levels of mRNA for c-kit, GATA-2, p45 NF-E2, and c-myb and low levels or no mRNA for c-fms and the receptors for granulocyte colony-stimulating factor and interleukins 5 and 7. Proc Natl Acad Sci USA. 92:1995;4601.
25. + human leukemia-derived cell lines. Blood. 84:1994;1074.
26. Persons D.A., Allay J.A., Allay E.R.et al. Enforced expression of the GATA-2 transcription factor blocks normal hematopoiesis. Blood. 93:1999;488.
27. Tsai F.Y., Keller G., Kuo F.C.et al. An early haematopoietic defect in mice lacking the transcription factor GATA-2. Nature. 371:1994;221.
28. Glimm H., Eaves C.J. Direct evidence for multiple self-renewal divisions of human in vivo repopulating hematopoietic cells in short-term culture. Blood. 94:1999;2161.